NASDAQ:IVTY Invuity (IVTY) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free IVTY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$7.39▼$7.3950-Day Range N/A52-Week Range$2.35▼$9.55VolumeN/AAverage Volume324,995 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Invuity alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About Invuity Stock (NASDAQ:IVTY)Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities. It offers various illuminated surgical devices, including Eikon LT illuminated retractor system for breast/oncoplastic/gynecology/EP/plastic/endocrine surgeries; Eiberg illuminated retractor systems for orthopedic surgeries; PhotonBlade, a recision illuminator for breast/plastics/EP/orthopedics surgeries; PhotonSaber Y, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general/gynecology/plastic surgeries; and PhotonSaber F, a handheld illuminator for spine/orthopedic/neurosurgery surgeries. The company also provides Breiten illuminated retractor systems for spine/orthopedic surgeries; Photonguide XT system, a drop-in intracavity illuminator for spine surgeries; Eika illuminated retractor systems for endocrine/spine/orthopedic surgeries; and PhotonVue, a system used in conjunction with IC Indocyanine for identifying and verifying blood flow in tissue, as well as is used in breast/plastic/colorectal surgeries. It sells its devices through direct sales representatives and independent sales agents; and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. The company was formerly known as Spotlight Surgical, Inc. and changed its name to Invuity, Inc. in 2007. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California.Read More Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. IVTY Stock News HeadlinesOctober 28, 2023 | foxnews.comTop law firm rescinds job offers to Ivy League students who signed letter blaming Israel for violenceOctober 23, 2023 | usatoday.comIvy Queen receives Billboard Icon Award, reflects on difficult road to reggaeton successApril 27, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.September 27, 2023 | usatoday.comKelly Rowland says she's 'very proud' of Blue Ivy amid performance's for Beyoncé's tourAugust 16, 2023 | nypost.comThis top college consultant gets students into the Ivy League for $1.5K per hourAugust 10, 2023 | thestreet.comStudy: Ivy League Colleges Aren’t Worth ItJune 16, 2023 | mirror.co.ukBeyonce and Jay Z's 'billion dollar baby' as they launch Blue Ivy's performing careerJune 13, 2023 | mirror.co.ukBeyoncé and Jay-Z's daughter Blue Ivy is 'a billion-dollar baby waiting for her moment'April 27, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.March 13, 2023 | nypost.comPrinceton vs. Penn pick, odds: Take favorite in this Ivy League clashFebruary 24, 2023 | finance.yahoo.comFLG Partners Increases Capacity for GrowthFebruary 20, 2023 | mirror.co.ukJay-Z and Blue Ivy, 11, in rare appearance together as youngster looks all grown upSee More Headlines Receive IVTY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invuity and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/02/2018Today4/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & Medical Instruments Sub-IndustryN/A Current SymbolNASDAQ:IVTY CUSIPN/A CIK1393020 Webwww.invuity.com Phone415-655-2100FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Scott D. Flora (Age 62)Interim Pres, CEO & Director Mr. Philip M. Sawyer (Age 53)CEO, Pres & Director Mr. James H. MacKaness (Age 54)Chief Financial Officer Mr. Douglas W. Heigel (Age 57)Sr. VP of Operations Ms. Marcia Fish (Age 54)Chief HR Officer Key CompetitorsNyxoahNASDAQ:NYXHStevanato GroupNYSE:STVN180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWAclarionNASDAQ:ACONWView All Competitors IVTY Stock Analysis - Frequently Asked Questions How were Invuity's earnings last quarter? Invuity, Inc. (NASDAQ:IVTY) issued its quarterly earnings data on Thursday, August, 2nd. The medical instruments supplier reported ($0.37) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.10. The medical instruments supplier had revenue of $10.50 million for the quarter, compared to analysts' expectations of $10.73 million. What other stocks do shareholders of Invuity own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invuity investors own include Cornerstone Strategic Value Fund (CLM), Allena Pharmaceuticals (ALNA), Madrigal Pharmaceuticals (MDGL), Mondi (MNDI), Spero Therapeutics (SPRO), AcelRx Pharmaceuticals (ACRX), Ekso Bionics (EKSO), Exelixis (EXEL) and Fate Therapeutics (FATE). When did Invuity IPO? Invuity (IVTY) raised $48 million in an initial public offering on the week of June 15th 2015. The company issued 4,000,000 shares at a price of $12.00 per share. Piper Jaffray, Leerink Partners and Stifel served as the underwriters for the IPO and William Blair was co-manager. This page (NASDAQ:IVTY) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invuity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.